Left ventricular dysfunction assessed by speckle-tracking strain analysis in patients with systemic sclerosis: Relationship to functional capacity and ventricular arrhythmias

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 3969-3978

  Yiu, Kai Hang ^a,b,c   Schouffoer, Anne A ^a   Marsan, Nina Ajmone ^a,c   Ninaber, Maarten K ^a   Stolk, Jan ^a   Vlieland, Thea Vliet ^a   Scherptong, Roderick W ^a   Delgado, Victoria ^a   Holman, Eduard R ^a   Tse, Hung Fat ^b   Huizinga, Tom W J ^a   Bax, Jeroen J ^a   Schuerwegh, Annemie J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; CARDIOPULMONARY FUNCTION; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; FUNCTIONAL STATUS; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FAILURE; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE TACHYCARDIA; HOLTER MONITORING; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SPECKLE TRACKING STRAIN ANALYSIS; SYSTEMIC SCLEROSIS; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADULT; AGED; ARRHYTHMIAS, CARDIAC; CASE-CONTROL STUDIES; COMORBIDITY; CROSS-SECTIONAL STUDIES; ECHOCARDIOGRAPHY, DOPPLER; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OXYGEN CONSUMPTION; RISK FACTORS; SCLERODERMA, SYSTEMIC; VENTRICULAR DYSFUNCTION, LEFT;

EID: 82455210463     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30614     Document Type: Article

References (32)

1. Bryan C, Knight C, Black CM, Silman AJ,. Prediction of five-year survival following presentation with scleroderma: development of a simple model using three disease factors at first visit. Arthritis Rheum 1999; 42: 2660-5. (Pubitemid 30327188)
2. Tyndall AJ, Bannert B, Vonk M, Airo P, Cozzi F, Carreira PE, et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann Rheum Dis 2010; 69: 1809-15.
3. Follansbee WP, Miller TR, Cirtoss EI, Orie JE, Bernstein RL, Kiernan JM, et al. A controlled clinicopathologic study of myocardial fibrosis in systemic sclerosis (scleroderma). J Rheumatol 1990; 17: 656-62. (Pubitemid 20201743)
4. Allanore Y, Meune C, Vonk MC, Airo P, Hachulla E, Caramaschi P, et al. Prevalence and factors associated with left ventricular dysfunction in the EULAR Scleroderma Trial and Research group (EUSTAR) database of patients with systemic sclerosis. Ann Rheum Dis 2010; 69: 218-21.
5. Mele D, Censi S, La Corte R, Lo Monaco A, Locaputo A, Ceconi C, et al. Abnormalities of left ventricular function in asymptomatic patients with systemic sclerosis using Doppler measures of myocardial strain. J Am Soc Echocardiogr 2008; 21: 1257-64.
6. Kepez A, Akdogan A, Sade LE, Deniz A, Kalyoncu U, Karadag O, et al. Detection of subclinical cardiac involvement in systemic sclerosis by echocardiographic strain imaging. Echocardiography 2008; 25: 191-7. (Pubitemid 351199002)
7. D'Andrea A, Stisi S, Bellissimo S, Vigorito F, Scotto di, Uccio F, Tozzi N, et al. Early impairment of myocardial function in systemic sclerosis: non-invasive assessment by Doppler myocardial and strain rate imaging. Eur J Echocardiogr 2005; 6: 407-18. (Pubitemid 41700711)
8. Blessberger H, Binder T,. Two dimensional speckle tracking echocardiography: basic principles. Heart 2010; 96: 716-22.
9. Schuerwegh AJ, Schouffoer AA, Beaart-van deVoorde LJ, Tromp FJ, Ninaber MK, Huizinga TW, et al. Yearly, standardized, comprehensive assessment and treatment advice for patients with systemic sclerosis (SSc): feasibility of a day care program [abstract]. Arthritis Rheum 2009: 60 Suppl: S427-8.
10. Schouffoer AA, Ninaber MK, Beaart-van de Voorde LJ, van der Giesen FJ, de Jong Z, Stolk J, et al. Randomized comparison of a multidisciplinary team care program with usual care in patients with systemic sclerosis. Arthritis Care Res (Hoboken) 2011; 63: 909-17.
11. Clements P, Lachenbruch P, Siebold J, White B, Weiner S, Martin R, et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281-5.
12. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202-5. (Pubitemid 18073738)
13. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319-38. (Pubitemid 41079078)
14. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F, et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005; 26: 511-22. (Pubitemid 41264217)
15. MacIntyre N, Crapo RO, Viegi G, Johnson DC, van der Grinten CP, Brusasco V, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J 2005; 26: 720-35. (Pubitemid 41448672)
16. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005; 18: 1440-63. (Pubitemid 41821197)
17. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107-33.
18. McQuillan BM, Picard MH, Leavitt M, Weyman AE,. Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation 2001; 104: 2797-802. (Pubitemid 33126653)
19. Kircher BJ, Himelman RB, Schiller NB,. Noninvasive estimation of right atrial pressure from the inspiratory collapse of the inferior vena cava. Am J Cardiol 1990; 66: 493-6. (Pubitemid 20259386)
20. Delgado V, Ypenburg C, van Bommel RJ, Tops LF, Mollema SA, Marsan NA, et al. Assessment of left ventricular dyssynchrony by speckle tracking strain imaging comparison between longitudinal, circumferential, and radial strain in cardiac resynchronization therapy. J Am Coll Cardiol 2008; 51: 1944-52. (Pubitemid 351636442)
21. American Thoracic Society/American College of Chest Physicians. ATS/ACCP statement on cardiopulmonary exercise testing [published erratum appears in Am J Respir Crit Care Med 2003;167:1451-2]. Am J Respir Crit Care Med 2003; 167: 211-77.
22. Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-90. (Pubitemid 40704507)
23. De Groote P, Gressin V, Hachulla E, Carpentier P, Guillevin L, Kahan A, et al, for the ItinerAIR-Scleroderma Investigators. Evaluation of cardiac abnormalities by Doppler echocardiography in a large nationwide multicentric cohort of patients with systemic sclerosis. Ann Rheum Dis 2008; 67: 31-6.
24. Follansbee WP, Curtiss EI, Medsger TA Jr, Steen VD, Uretsky BF, Owens GR, et al. Physiologic abnormalities of cardiac function in progressive systemic sclerosis with diffuse scleroderma. N Engl J Med 1984; 310: 142-8. (Pubitemid 14224107)
25. Tzelepis GE, Kelekis NL, Plastiras SC, Mitseas P, Economopoulos N, Kampolis C, et al. Pattern and distribution of myocardial fibrosis in systemic sclerosis: a delayed enhanced magnetic resonance imaging study. Arthritis Rheum 2007; 56: 3827-36. (Pubitemid 350100715)
26. Hachulla AL, Launay D, Gaxotte V, de Groote P, Lamblin N, Devos P, et al. Cardiac magnetic resonance imaging in systemic sclerosis: a cross-sectional observational study of 52 patients. Ann Rheum Dis 2009; 68: 1878-84.
27. Sudduth CD, Strange C, Cook WR, Miller KS, Baumann M, Collop NA, et al. Failure of the circulatory system limits exercise performance in patients with systemic sclerosis. Am J Med 1993; 95: 413-8. (Pubitemid 23303071)
28. Alkotob ML, Soltani P, Sheatt MA, Katsetos MC, Rothfield N, Hager WD, et al. Reduced exercise capacity and stress-induced pulmonary hypertension in patients with scleroderma. Chest 2006; 130: 176-81. (Pubitemid 44116857)
29. Walkey AJ, Ieong M, Alikhan M, Farber HW,. Cardiopulmonary exercise testing with right-heart catheterization in patients with systemic sclerosis. J Rheumatol 2010; 37: 1871-7.
30. Kovacs G, Maier R, Aberer E, Brodmann M, Scheidl S, Troster N, et al. Borderline pulmonary arterial pressure is associated with decreased exercise capacity in scleroderma. Am J Respir Crit Care Med 2009; 180: 881-6.
31. Schwaiblmair M, Behr J, Fruhmann G,. Cardiorespiratory responses to incremental exercise in patients with systemic sclerosis. Chest 1996; 110: 1520-5. (Pubitemid 26425154)
32. Kostis JB, Seibold JR, Turkevich D, Masi AT, Grau RG, Medsger TA Jr, et al. Prognostic importance of cardiac arrhythmias in systemic sclerosis. Am J Med 1988; 84: 1007-15.